Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orla Hardiman

Showing results (111-120 of 426) with videos related to

Pageof 43
Sort By:
Stem Cell Research|September 13, 2019
Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C)Meimei Yang, Min Liu, Alice Vajda, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 7, 2011
Proposed criteria for familial amyotrophic lateral sclerosisSusan Byrne, Peter Bede, Marwa Elamin, et al.
Clinical Neurology and Neurosurgery|January 20, 2009
A case of stiff-person syndrome, type 1 diabetes, celiac disease and dermatitis herpetiformisEoin P O'Sullivan, Lucy-Ann Behan, Tom F J King, et al.
American Journal of Respiratory and Critical Care Medicine|November 2, 2004
Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosisRoss K Morgan, Stephen McNally, Michael Alexander, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 25, 2017
Estimation of coherence using the median is robust against EEG artefactsStefan Dukic, Parameswaran Mahadeva Iyer, Kieran Mohr, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 13, 2019
Two heads are better than one: benefits of joint models for ALS trialsRuben P A van Eijk, James Rooney, Orla Hardiman, et al.
PLOS Digital Health|March 10, 2025
Clinical validation of a novel hand dexterity measurement deviceConor D Hayden, Bruce P Murphy, Deirdre Gilsenan, et al.
Pharmacoeconomics|May 31, 2024
A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health TechnologiesPaul Tappenden, Orla Hardiman, Sun-Hong Kwon, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2015
A revision of the El Escorial criteria - 2015Albert Ludolph, Vivian Drory, Orla Hardiman, et al.
Journal of Neurology|July 14, 2025
Neurophysiological biomarkers of networks impairment in amyotrophic lateral sclerosisAntonio Fasano, Veria Vacchiano, Luigi Bonan, et al.
Pageof 43

Showing results (111-120 of 426) with videos related to

Sort By:
Pageof 43
Stem Cell Research|September 13, 2019
Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C)Meimei Yang, Min Liu, Alice Vajda, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 7, 2011
Proposed criteria for familial amyotrophic lateral sclerosisSusan Byrne, Peter Bede, Marwa Elamin, et al.
Clinical Neurology and Neurosurgery|January 20, 2009
A case of stiff-person syndrome, type 1 diabetes, celiac disease and dermatitis herpetiformisEoin P O'Sullivan, Lucy-Ann Behan, Tom F J King, et al.
American Journal of Respiratory and Critical Care Medicine|November 2, 2004
Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosisRoss K Morgan, Stephen McNally, Michael Alexander, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 25, 2017
Estimation of coherence using the median is robust against EEG artefactsStefan Dukic, Parameswaran Mahadeva Iyer, Kieran Mohr, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 13, 2019
Two heads are better than one: benefits of joint models for ALS trialsRuben P A van Eijk, James Rooney, Orla Hardiman, et al.
PLOS Digital Health|March 10, 2025
Clinical validation of a novel hand dexterity measurement deviceConor D Hayden, Bruce P Murphy, Deirdre Gilsenan, et al.
Pharmacoeconomics|May 31, 2024
A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health TechnologiesPaul Tappenden, Orla Hardiman, Sun-Hong Kwon, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2015
A revision of the El Escorial criteria - 2015Albert Ludolph, Vivian Drory, Orla Hardiman, et al.
Journal of Neurology|July 14, 2025
Neurophysiological biomarkers of networks impairment in amyotrophic lateral sclerosisAntonio Fasano, Veria Vacchiano, Luigi Bonan, et al.
Pageof 43